Published results from the ISS TAVIS experiment demonstrate a microgravity effect on chemotherapy response in colorectal cancer models.
Researchers deployed colorectal cancer models to the ISS to study drug resistance in microgravity. Resolution depends on peer-reviewed study publication.
Across 6 frontier models answering independently, the panel is barely on the yes side: the median is 63%.
They do not agree: Gemini puts it at 74% and Claude at 35%, 39 points apart. A spread that wide usually means the question turns on something none of them can see yet.
Nothing is settled until 15 Nov 2029, when the outcome is checked against sources and every number above gets a permanent score.
What each one said
-
GeminiGoogle
Resolution turns on whether peer-reviewed analysis finds statistically significant differential chemoresponse before late 2029.
- A three-year horizon gives the research team ample time to complete terrestrial genomic sequencing, assays, and peer-reviewed publication.
- Prior ISS 3D-organoid experiments consistently show microgravity alters cell morphology and drug permeability, favoring positive findings.
- A null drug-response finding or severe sample degradation upon Earth return represents the primary risk to confirmation.
74% -
DeepSeekDeepSeek
Whether the TAVIS team completes peer review and publishes by late 2029.
- TAVIS hardware flew to ISS in 2024-2025, but sample return, processing, and peer review typically take 2-4 years after splashdown.
- The experiment is a collaboration between NASA and academic groups; publication depends on their timeline, not on any external regulatory approval.
- Base rate for ISS life-science experiments yielding peer-reviewed results within 3-5 years of flight is roughly 60-70%, and this one has no known major delays.
68% -
GPTOpenAI
The key uncertainty is whether the ISS team converts its flight data into a peer-reviewed paper with a clear treatment-response result.
- Investigators must recover, analyze, replicate or validate flight findings, then clear journal peer review before 15 November 2029.
- ISS biology payloads often yield publications within 2–5 years, but oncology models can suffer limited sample size and ambiguous controls.
- A preprint, conference abstract, or a named journal manuscript showing differential chemotherapy response would raise this sharply.
63% -
GrokxAI
TAVIS return-to-publication lag and whether the CRC models actually show a chemo-response difference vs 1g.
- ISS bio payloads typically produce a first paper 12-24 months after sample return; three years remain after 2026.
- Spaceflight CRC/organoid studies more often report transcriptomic or viability shifts than true nulls, lifting this above a 40% null-result base.
- A delayed sample-return, failed controls, or a purely descriptive methods paper would most lower the odds.
62% -
QwenAlibaba
Turns on whether TAVIS data yields statistically significant differential drug response and clears peer review by late 2029.
- ISS cancer experiments (e.g., PCAT, Tumor Spheroid studies) typically take 18–30 months from sample return to publication, fitting the 3-year window if deployment…
- Positive demonstration requires a clear, reproducible effect size in chemotherapy sensitivity under microgravity versus ground controls—several prior ISS oncology…
- Would raise estimate if a preprint or conference abstract from the TAVIS team appeared before mid-2028, signaling data are mature enough for journal submission.
37% -
ClaudeAnthropic
Hinges on whether TAVIS data get through peer review and show a clear microgravity-chemo effect by Nov 2029.
- ISS biology experiments often take 2-4 years from flight to peer-reviewed publication, leaving a plausible but not generous window.
- Many spaceflight cancer studies report some biological effect, but showing a specific, statistically robust chemo-resistance signal is a higher bar.
- Risk factors: funding gaps, inconclusive or null results, or publication delays pushing past 2029 would lower this; an early preprint with strong effect size would raise…
35%
6 of 6 models answered · 39 points between the highest and lowest. None was shown the market price.
Question sourced from a news sweep on 16 Nov 2026. Forecast by google/gemini-3.8-flash, anthropic/claude-sonnet-5, openai/gpt-5.6-terra, x-ai/grok-4.6, deepseek/deepseek-v4.1-flash, qwen/qwen3.8-max-0902 via OpenRouter.